Proteomic changes in rat thyroarytenoid muscle induced by botulinum neurotoxin injection

Proteomics

Volumn 8, Issue 9, 2008, Pages 1933-1944

  Welham, Nathan V ^a,c   Marriott, Gerard ^a   Tateya, Ichiro ^b   Bless, Diane M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b KYOTO KATSURA HOSPITAL   (Japan)

^c K4/723 CSC ^*  (United States)

Author keywords

Botulinum toxin; Mass spectrometry; Thyroarytenoid muscle; Two dimensional gel electrophoresis

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; MYOSIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENERGY METABOLISM; LARYNX MUSCLE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUSCLE CONTRACTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SPRAGUE DAWLEY RAT; THYROID GLAND; VOCAL CORD;

ANIMALS; BOTULINUM TOXINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; LARYNGEAL MUSCLES; MALE; MASS SPECTROMETRY; MODELS, ANATOMIC; MYOSIN HEAVY CHAINS; PROTEOMICS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

RATTUS;

EID: 43549092842     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700859     Document Type: Article

References (45)

1. Dressler, D., Adib Saberi, F., Botulinum toxin: Mechanisms of action. Eur. Neurol. 2005, 53, 3-9.
2. Turton, K., Chaddock, J. A., Acharya, K. R., Botulinum and tetanus neurotoxins: Structure, function and therapeutic utility. Trends Biochem. Sci. 2002, 27, 552-558.
3. Boutsen, F., Cannito, M. P., Taylor, M., Bender, B., Botox treatment in adductor spasmodic dysphonia: A meta-analysis. J. Speech Lang. Hear. Res. 2002, 45, 469-481.
4. Costa, J., Espirito-Santo, C., Borges, A., Ferreira, J. et al., Botulinum toxin type B for cervical dystonia. Cochrane Database Syst. Rev. 2004, 4, CD004315.
5. Costa, J., Espirito-Santo, C., Borges, A., Ferreira, J. et al., Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst. Rev. 2004, 4, CD004900.
6. Truong, D., Duane, D. D., Jankovic, J., Singer, C. et al., Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study. Mov. Disord. 2005, 20, 783-791.
7. El-Etribi, M. A., Salem, M. E., El-Shakankiry, H. M., El-Kahky, A. M., El-Mahboub, S. M., The effect of botulinum toxin type-A injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy: An Egyptian study. Int. J. Rehabil. Res. 2004, 27, 275-281.
8. Brashear, A., Gordon, M. F., Elovic, E., Kassicieh, V. D. et al., Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N. Engl. J. Med. 2002, 347, 395-400.
9. Yamauchi, P. S., Lowe, N. J., Botulinum toxin types A and B: Comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis. Clin. Dermatol. 2004, 22, 34-39.
10. Fitzgerald, E., Feeley, T. M., Tierney, S., Current treatments for axillary hyperhidrosis. Surgeon 2004, 2, 311-314.
11. Nelson, L., Bachoo, P., Holmes, J., Botulinum toxin type B: A new therapy for axillary hyperhidrosis. Br. J. Plast. Surg. 2005, 58, 228-232.
12. Kamanli, A., Kaya, A., Ardicoglu, O., Ozgocmen, S. et al., Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol. Int. 2005, 25, 604-611.
13. Smuts, J. A., Schultz, D., Barnard, A., Mechanism of action of botulinum toxin type A in migraine prevention: A pilot study. Headache 2004, 44, 801-805.
14. Inagi, K., Connor, N. P., Schultz, E., Ford, C. N. et al., Increased acute and chronic mitotic activity in rat laryngeal muscles after botulinum toxin injection. Laryngoscope 1998, 108, 1055-1061.
15. Chhetri, D. K., Blumin, J. H., Vinters, H. V., Berke, G. S., Histology of nerves and muscles in adductor spasmodic dysphonia. Ann. Otol. Rhinol. Laryngol. 2003, 112, 334-341.
16. Inagi, K., Ford, C. N., Rodriquez, A. A., Schultz, E. et al., Efficacy of repeated botulinum toxin injections as a function of timing. Ann. Otol. Rhinol. Laryngol. 1997, 106, 1012-1019.
17. Inagi, K., Connor, N. P., Schultz, E., Ford, C. N. et al., Muscle fiber-type changes induced by botulinum toxin injection in the rat larynx. Otolaryngol. Head Neck Surg. 1999, 120, 876-883.
18. Li, Z. B., Lehar, M., Samlan, R., Flint, P. W., Proteomic analysis of rat laryngeal muscle following denervation. Proteomics 2005, 5, 4764-4776.
19. Inagi, K., Connor, N. P., Ford, C. N., Schultz, E. et al., Physiologic assessment of botulinum toxin effects in the rat larynx. Laryngoscope 1998, 108, 1048-1054.
20. Suzuki, T., Connor, N. P., Lee, K., Leverson, G., Ford, C. N., Laryngeal-respiratory kinematics are impaired in aged rats. Ann. Otol. Rhinol. Laryngol. 2002, 111, 684-689.
21. Inagi, K., Rodriquez, A. A., Ford, C. N., Heisey, D. M., Transoral electromyographic recordings in botulinum toxin-injected rat larynges. Ann. Otol. Rhinol. Laryngol. 1997, 106, 956-964.
22. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K. et al., Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150, 76-85.
23. O'Farrell, P. H., High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
24. Oakley, B. R., Kirsch, D. R., Morris, N. R., A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal. Biochem. 1980, 105, 361-363.
25. Appel, R. D., Vargas, J. R., Palagi, R M., Walther, D., Hochstrasser, D. F., Melanie II - a third-generation software package for analysis of two-dimensional electrophoresis images: II. Algorithms. Electrophoresis 1997, 18, 2735-2748.
26. Appel, R. D., Palagi, P. M., Walther, D., Vargas, J. R. et al., Melanie II - a third-generation software package for analysis of two-dimensional electrophoresis images: I. Features and user interface. Electrophoresis 1997, 18, 2724-2734.
27. Swiss Institute of Bioinformatics, Melanie: The 2-D Gel Analysis Software. User Manual for Version 4.02, Author, Geneva 2003.
28. Welham, N. V., Marriott, G., Bless, D. M., Proteomic profiling of rat thyroarytenoid muscle. J. Speech Lang. Hear. Res. 2006, 49, 671-685.
29. Bland, J. M., Altman, D. G., Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 327, 307-310.
30. Das, A. M., Regulation of the mitochondrial ATP-synthase in health and disease. Mol. Genet. Metab. 2003, 79, 71-82.
31. Isfort, R. J., Wang, F., Greis, K. D., Sun, Y. et al., Proteomic analysis of rat soleus muscle undergoing hindlimb suspension-induced atrophy and reweighting hypertrophy. Proteomics 2002, 2, 543-550.
32. Isfort, R. J., Hinkle, R. T., Jones, M. B., Wang, F. et al., Proteomic analysis of the atrophying rat soleus muscle following denervation. Electrophoresis 2000, 21, 2228-2234.
33. Nozais, M., Merkulova, T., Keller, A., Janmot, C. et al., Denervation of rabbit gastrocnemius and soleus muscles: Effect on muscle-specific enolase. Eur. J. Biochem. 1999, 263, 195-201.
34. Piec, I., Listrat, A., Alliot, J., Chambon, C. et al., Differential proteome analysis of aging in rat skeletal muscle. FASEB J. 2005, 19, 1143-1145.
35. Sun, H., Liu, J., Ding, F., Wang, X. et al., Investigation of differentially expressed proteins in rat gastrocnemius muscle during denervation-reinnervation. J. Muscle Res. Cell Motil. 2006, 27, 241-250.
36. O'Connell, K., Gannon, J., Doran, P., Ohlendieck, K., Proteomic profiling reveals a severely perturbed protein expression pattern in aged skeletal muscle. Int. J. Mol. Med. 2007, 20, 145-153.
37. Yan, J. X., Harry, R. A., Wait, R., Welson, S. Y. et al., Separation and identification of rat skeletal muscle proteins using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2001, 1, 424-434.
38. Culotta, V. C., Yang, M., O'Halloran, T. V., Activation of superoxide dismutases: Putting the metal to the pedal. Biochim. Biophys. Acta 2006, 1763, 747-758.
39. Rhee, S. G., Chae, H. Z., Kim, K., Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38, 1543-1552.
40. Mishra, S., Murphy, L. C., Murphy, L. J., The Prohibitins: Emerging roles in diverse functions. J. Cell. Mol. Med. 2006, 10, 353-363.
41. Parmeggiani, A., Nissen, P., Elongation factor Tu-targeted antibiotics: Four different structures, two mechanisms of action. FEBS Lett. 2006, 580, 4576-4581.
42. Speeckaert, M., Huang, G., Delanghe, J. R., Taes, Y. E., Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta 2006, 372, 33-42.
43. Nagradova, N., Enzymes catalyzing protein folding and their cellular functions. Curr. Protein Pept. Sci. 2007, 8, 273-282.
44. Hassan, S. M., Jennekens, F. G., Veldman, H., Botulinum toxin-induced myopathy in the rat. Brain 1995, 118, 533-545.
45. Smolka, M., Zhou, H., Aebersold, R., Quantitative protein profiling using two-dimensional gel electrophoresis, isotope-coded affinity tag labeling, and mass spectrometry. Mol. Cell. Proteomics 2002, 1, 19-29.